IRIS
TUMBARELLO, MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.655
EU - Europa 5.563
AS - Asia 3.899
SA - Sud America 792
Continente sconosciuto - Info sul continente non disponibili 367
AF - Africa 235
OC - Oceania 11
Totale 24.522
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.445
IT - Italia 2.258
RU - Federazione Russa 1.371
SG - Singapore 1.149
CN - Cina 939
BR - Brasile 647
VN - Vietnam 453
IE - Irlanda 440
HK - Hong Kong 395
KR - Corea 281
DE - Germania 239
FR - Francia 237
GB - Regno Unito 232
BD - Bangladesh 229
FI - Finlandia 169
SE - Svezia 168
NL - Olanda 136
ZA - Sudafrica 136
IN - India 132
CA - Canada 113
ES - Italia 51
PL - Polonia 45
MX - Messico 43
AT - Austria 40
IQ - Iraq 40
UA - Ucraina 38
AR - Argentina 37
CO - Colombia 31
JP - Giappone 31
TR - Turchia 29
EC - Ecuador 27
CZ - Repubblica Ceca 25
CI - Costa d'Avorio 24
ID - Indonesia 22
SA - Arabia Saudita 20
EG - Egitto 18
CH - Svizzera 17
UZ - Uzbekistan 17
AE - Emirati Arabi Uniti 16
KE - Kenya 16
LT - Lituania 15
BE - Belgio 14
MY - Malesia 14
PK - Pakistan 14
CR - Costa Rica 13
JO - Giordania 13
VE - Venezuela 13
PE - Perù 12
CL - Cile 11
IR - Iran 11
MA - Marocco 11
JM - Giamaica 9
PY - Paraguay 9
AU - Australia 8
PH - Filippine 8
BG - Bulgaria 7
BH - Bahrain 7
IL - Israele 7
NG - Nigeria 7
PT - Portogallo 7
GE - Georgia 6
PS - Palestinian Territory 6
AL - Albania 5
AZ - Azerbaigian 5
ET - Etiopia 5
GT - Guatemala 5
HN - Honduras 5
HR - Croazia 5
KZ - Kazakistan 5
LB - Libano 5
LK - Sri Lanka 5
LU - Lussemburgo 5
LV - Lettonia 5
TH - Thailandia 5
DK - Danimarca 4
HU - Ungheria 4
KG - Kirghizistan 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
YE - Yemen 4
AM - Armenia 3
BY - Bielorussia 3
CY - Cipro 3
DZ - Algeria 3
EE - Estonia 3
GR - Grecia 3
NO - Norvegia 3
OM - Oman 3
RO - Romania 3
SC - Seychelles 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
TW - Taiwan 3
AO - Angola 2
BB - Barbados 2
BO - Bolivia 2
CG - Congo 2
DO - Repubblica Dominicana 2
FJ - Figi 2
IS - Islanda 2
Totale 24.115
Salva come PNG Salva come JPEG
Città #
Dallas 9.461
Singapore 701
Milan 599
San Jose 562
Moscow 453
Dublin 424
Hefei 385
Ashburn 378
Hong Kong 363
Santa Clara 343
Council Bluffs 297
Seoul 280
Los Angeles 194
Ho Chi Minh City 174
Rome 173
Florence 171
Beijing 150
Siena 142
New York 121
Chandler 116
Johannesburg 116
Helsinki 102
The Dalles 96
Lauterbourg 94
Southend 87
Munich 86
Hanoi 83
Chicago 75
São Paulo 62
Buffalo 58
Bengaluru 56
Fairfield 54
Columbus 50
Orem 47
Nuremberg 46
Figino 43
Princeton 43
London 38
Boardman 37
Shanghai 37
Brescia 36
Lappeenranta 34
Naples 32
Bologna 31
Frankfurt am Main 31
Montreal 30
Turin 29
Turku 29
Toronto 28
Seattle 27
Tokyo 26
Phoenix 25
Rio de Janeiro 25
Warsaw 25
Abidjan 24
Houston 23
Da Nang 22
Redondo Beach 22
Washington 21
Denver 20
Paris 20
Vienna 20
Boston 19
Brasília 18
Brooklyn 18
Jacksonville 18
Portsmouth 18
Stockholm 18
Woodbridge 18
Gdynia 17
Atlanta 16
Chennai 16
Curitiba 16
Düsseldorf 16
Hải Dương 16
Wilmington 16
Baghdad 15
Catania 15
Genoa 15
Haiphong 15
Mexico City 15
Málaga 15
Newark 15
Palermo 15
Tashkent 15
Charlotte 14
San Francisco 14
Brussels 13
Cape Town 13
Guangzhou 13
Mumbai 13
Salt Lake City 13
San Diego 13
Zurich 13
Amman 12
Amsterdam 12
Belo Horizonte 12
Cairo 12
Poplar 12
Bari 11
Totale 17.942
Salva come PNG Salva come JPEG
Nome #
(1,3)-β-d-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: A randomized trial 7.263
Compassionate use of meropenem/vaborbactam for infections caused by KPC-producing Klebsiella pneumoniae: a multicentre study 642
A first update on mapping the human genetic architecture of COVID-19 613
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 556
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 450
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 398
An explainable model of host genetic interactions linked to COVID-19 severity 396
Pathogen-sugar interactions revealed by universal saturation transfer analysis 380
Mapping the human genetic architecture of COVID-19 334
Colonizzazione e trapianto di polmone: il possibile ruolo dei colonizzanti multiresistenti sugli eventi infettivi in uno studio pilota osservazionale-retrospettivo 332
Programma di vaccinazione antiMpox e screening infettivologico: opportunità di prevenzione in differenti categorie a rischio 320
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 320
Long Covid: analisi di casistica in follow-up a seguito di successive ondate epidemiche 318
Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19 309
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 292
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV 290
Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes 270
Severe COVID-19 in hospitalized carriers of single CFTR pathogenic variants 250
Ultra-rare RTEL1 gene variants associate with acute severity of COVID-19 and evolution to pulmonary fibrosis as a specific long COVID disorder 236
B cell response six months after SARS-CoV-2 mRNA vaccination in people living with HIV under antiretroviral therapy 229
Prevalence, Incidence and Predictors of Anal HPV Infection and HPV-Related Squamous Intraepithelial Lesions in a Cohort of People Living with HIV 229
Whole-genome sequencing reveals host factors underlying critical COVID-19 227
Antigenic sin and multiple breakthrough infections drive converging evolution of COVID-19 neutralizing responses 210
Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound? 207
Urinary tract infections caused by Gram-negative bacteria in elderly hospitalized patients: epidemiology, clinical features and outcomes in the era of antimicrobial resistance 206
Colonizzazione da batteri multiresistenti nel trapianto di polmone ed eventi infettivi: studio pilota osservazionale-retrospettivo 198
ACKNOWLEDGEMENT OF REVIEWERS 197
B cell analyses after SARS-CoV-2 mRNA third vaccination reveals a hybrid immunity like antibody response 196
Polypharmacy, anticholinergic burden and drug-drug interaction assessment in people with four-class-resistant HIV: data from the PRESTIGIO registry 193
An Observational Study to Develop a Predictive Model for Bacterial Pneumonia Diagnosis in Severe COVID-19 Patients—C19-PNEUMOSCORE 186
Staphylococcus aureus ventilator-associated pneumonia in patients with COVID-19: clinical features and potential inference with lung dysbiosis 182
Ceftazidime-avibactam use for klebsiella pneumoniae carbapenemase-producing k. pneumoniae infections: a retrospective observational multicenter study 175
Evolution of anal HPV infection and HPV-related squamous intraepithelial lesions in a cohort of PLWH: is there a benefit of HPV vaccination? 172
Patient profile characteristics when choosing different Dolutegravir-based dual therapies: impact on long term efficacy and durability 170
Evaluation of the New NucliSENS EasyQ KPC Test for Rapid Detection of Klebsiella pneumoniae Carbapenemase Gene (blaKPC) 170
Ceftolozane/tazobactam for treatment of severe ESBL-producing enterobacterales infections: A multicenter nationwide clinical experience (CEFTABUSE II Study) 169
PRESTIGIO RING “a 59-year-old man with multidrug resistant HIV-1 infection failing a regimen including dolutegravir, rilpivirine, atazanavir/cobicistat: successful treatment tailoring based on genotypic and phenotypic resistance tests” 167
Trattamento efficace di osteomielite sternale con raccolta purulenta da Klebsiella pneumoniae multiresistente in recente trapianto di polmone 167
High prevalence of Hepatic Steatosis in a cohort of People Living With HIV: exploring the role of metabolic and HIV-related factors 166
Clinical impact of ceftazidime/avibactam on the treatment of suspected or proven infections in a large cohort of patients with haematological malignancies: a multicentre observational real-world study 166
Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA Vaccine 164
Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: updated epidemiology and risk factors for multidrug-resistant strains in an Italian perspective survey 159
Vaccinazione anti SARSCov2 in una coorte di pazienti sottoposti a trapianto di cuore o di polmone: risposta umorale a dosi booster 159
Safety and Efficacy of Outpatient Treatments for COVID-19: Real-Life Data from a Regionwide Cohort of High-Risk Patients in Tuscany, Italy (the FEDERATE Cohort) 159
Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants 159
Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant 156
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry 156
Efficacy and Durability of Dolutegravir- or Darunavir-Based Regimens in ART-Naïve AIDS- or Late-Presenting HIV-Infected Patients. 154
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine) 154
Fatal inflammatory AIDS-associated PML with high CD4 counts on HAART: a new clinical entity? 151
Successivi booster vaccinali contro SARS-CoV-2: risposta umorale in pazienti sottoposti a trapianto di cuore o di polmone 147
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 144
Prevalence and correlates of Hepatic Steatosis and Metabolic-associated Fatty Liver Disease in a cohort of People Living With HIV 144
Outcomes and Predictors of Mortality in Patients With KPC-Kp Infections Treated With Meropenem Vaborbactam: An Observational Multicenter Study 143
Liver fibrosis stage predicts early treatment outcomes with peginterferon plus ribavirin in HIV/hepatitis C virus co-infected patients 140
Rapid Decrease in Fluoroquinolones Consumption following Implementation of a Simple Antimicrobial Stewardship Bundled Intervention in a University Hospital during the COVID-19 Pandemic 139
Third Sars-CoV-2 vaccine dose: B cell and antibody responses following heterologous and homologous vaccination strategies. 133
Meropenem-vaborbactam as intrathecal-sparing therapy for the treatment of carbapenem-resistant K. pneumoniae shunt-related ventriculitis: two case reports and review of the literature 132
Bloodstream infections caused by Escherichia coli in onco-haematological patients: Risk factors and mortality in an Italian prospective survey 131
Successful treatment of complicated infective endocarditis due to Enterococcus faecium in a patient with substance use disorder using oritavancin as sequential maintenance therapy 124
Diagnosis and management of infections caused by multidrug-resistant bacteria: guideline endorsed by the Italian Society of Infection and Tropical Diseases (SIMIT), the Italian Society of Anti-Infective Therapy (SITA), the Italian Group for Antimicrobial Stewardship (GISA), the Italian Association of Clinical Microbiologists (AMCLI) and the Italian Society of Microbiology (SIM) 124
The Uprise of Human Leishmaniasis in Tuscany, Central Italy: Clinical and Epidemiological Data from a Multicenter Study 124
Characterisation and risk factor profiling of Pseudomonas aeruginosa urinary tract infections: pinpointing those likely to be caused by multidrug-resistant strains 124
A new call for influenza and pneumococcal vaccinations during COVID-19 pandemic in Italy: A SIP/IRS (Italian Respiratory Society) and SITA (Italian Society of Antiinfective therapy) statement 124
Persistence of spike-specific memory B cells and antibodies nine months after two doses of BNT162b2 mRNA vaccine. 121
Epidemiology, aetiology and treatment of skin and soft tissue infections: final report of a prospective multicentre national registry 114
Adjunctive immunotherapeutic agents in patients with sepsis and septic shock: a multidisciplinary consensus of 23 112
Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections 111
Predictors for Prolonged Hospital Stay Solely to Complete Intravenous Antifungal Treatment in Patients with Candidemia: Results from the ECMM Candida III Multinational European Observational Cohort Study 108
Management of intra-abdominal infections: recommendations by the Italian council for the optimization of antimicrobial use 104
Considerations on antimicrobial prophylaxis in patients with lymphoproliferative diseases: A SEIFEM group position paper 103
Primary Cutaneous Cryptococcosis in an Immunocompetent Patient: Diagnostic Workflow and Choice of Treatment 102
New Drugs for the Treatment of Pseudomonas aeruginosa Infections with Limited Treatment Options: A Narrative Review 102
Risk Factors for Intra-Abdominal Candidiasis in Intensive Care Units: Results from EUCANDICU Study 99
Predictors of mortality in solid organ transplant recipients with bloodstream infections due to carbapenemase-producing Enterobacterales: The impact of cytomegalovirus disease and lymphopenia 98
XDR-Pseudomonas aeruginosa Outside the ICU: Is There Still Place for Colistin? 96
Evaluating cefiderocol in the treatment of multidrug-resistant gram-negative bacilli: A review of the emerging data 95
Molecular mechanisms, epidemiology, and clinical importance of β-lactam resistance in enterobacteriaceae 89
Risk factors for candidemia after open heart surgery: Results from a multicenter case-control study 89
Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae 88
Multicenter Observational Retrospective Study on Febrile Events in Patients with Acute Myeloid Leukemia Treated with Cpx-351 in "Real-Life": The SEIFEM Experience 87
Meropenem/vaborbactam: a next generation β-lactam β-lactamase inhibitor combination 86
Use of colistin in adult patients: A cross-sectional study 86
Identification of two anti-Candida antibodies associated with the survival of patients with candidemia 85
Clinical outcomes in elderly patients with infections caused by NDM-producing Klebsiella pneumoniae: results from a real-life retrospective single center study in an endemic area 84
Posterior Reversible Encephalopathy Syndrome After Intramuscular Oxygen-Ozone Therapy 79
Low rate of infectious mortality omitting fluoroquinolone prophylaxis in high-risk hematological patients, a single centre experience 75
How to tailor recommendations on the treatment of multi-drug resistant Gram-negative infections at country level integrating antibiotic stewardship principles within the GRADE-ADOLOPMENT framework 75
Invasive Respiratory Fungal Infections in COVID-19 Critically Ill Patients 75
Factors associated with inadequate intravenous colistin dosages: Post hoc analysis of a multicenter, cross-sectional study 75
SARS CoV 2 infection in chronic myelogenous leukemia: Severe hematological presentation 73
Cefiderocol therapy among immunocompromised adult patients: a descriptive analysis from a prospective, multicentre cohort study 71
SARS-CoV-2 infection in a highly experienced person living with HIV 70
Can we lower the burden of antimicrobial resistance (AMR) in heavily immunocompromised patients? A narrative review and call to action 66
Treatment of post-lung transplantation pneumonia with cefiderocol: a case series and insights from the literature 54
The role of rapid and advanced microbiological methods in critical care: 2025 Emanuele Russo Delphi consensus 51
Diagnostic challenges in Flaviviridae infections: first human case of Usutu virus aseptic meningitis in an immunocompetent subject in Italy 40
Machine learning approaches to dissect hybrid and vaccine-induced immunity 40
Enterococcus faecium bacteraemia: a multicentre observational study focused on risk factors for clinical and microbiological outcomes 33
Booster dose reshapes SARS-CoV-2 RBD-specific B cell immunity in people living with HIV 28
Totale 24.359
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.985
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.985
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022284 0 0 0 8 4 3 31 57 13 26 53 89
2022/2023773 38 82 91 65 36 109 98 85 56 34 59 20
2023/20241.021 48 34 101 65 52 197 292 53 10 40 43 86
2024/20253.486 149 98 250 144 452 204 337 203 244 206 344 855
2025/202617.300 568 3.313 7.173 1.228 1.372 309 993 281 318 544 499 702
2026/20271.457 569 323 522 43 0 0 0 0 0 0 0 0
Totale 24.522